Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
5,812,878
-
Shares change
-
-208,509
-
Total reported value, excl. options
-
$529,776,765
-
Value change
-
-$16,593,374
-
Put/Call ratio
-
3334%
-
Number of buys
-
51
-
Number of sells
-
75
-
Price
-
$91.13
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2025
As of 31 Mar 2025 VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) had 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,812,878 shares of stock of the company.
Largest 10 holders included Fisher Asset Management, LLC, GOLDMAN SACHS GROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, Avalon Trust Co, J.Safra Asset Management Corp, UBS Group AG, Miller Investment Management, LP, BANK OF AMERICA CORP /DE/, ADAMSBROWN WEALTH CONSULTANTS LLC, and Quadrature Capital Ltd.
This table shows 134 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.